APLT
Income statement / Annual
Last year (2023), Applied Therapeutics, Inc.'s total revenue was $9.99 M,
and the percentage change from the previous year is not available.
In 2023, Applied Therapeutics, Inc.'s net income was -$119.76 M.
See Applied Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$9.99 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$53.91 M |
$441,000.00 |
$415,000.00 |
$380,000.00 |
$23,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$43.91 M |
-$441,000.00 |
-$415,000.00 |
-$380,000.00 |
-$23,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
-4.39 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$53.91 M
|
$55.63 M
|
$62.57 M
|
$61.79 M
|
$32.35 M
|
$11.47 M
|
$3.70 M
|
| General & Administrative
Expenses |
$20.62 M
|
$27.32 M
|
$43.05 M
|
$32.68 M
|
$13.23 M
|
$2.05 M
|
$582,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$20.62 M
|
$27.32 M
|
$43.05 M
|
$32.68 M
|
$13.23 M
|
$2.05 M
|
$582,000.00
|
| Other Expenses |
$0.00 |
-$177,000.00 |
-$521,000.00 |
-$54,000.00 |
-$24,000.00 |
-$1.14 M |
$0.00 |
| Operating Expenses |
$74.18 M |
$82.95 M |
$105.62 M |
$94.47 M |
$45.58 M |
$13.52 M |
$4.29 M |
| Cost And Expenses |
$74.53 M |
$82.95 M |
$105.62 M |
$94.47 M |
$45.58 M |
$13.52 M |
$4.29 M |
| Interest Income |
$1.37 M |
$685,000.00 |
$555,000.00 |
$559,000.00 |
$93,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
-$442,000.00 |
$555,000.00 |
$559,000.00 |
$93,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$354,000.00
|
$441,000.00
|
$415,000.00
|
$380,000.00
|
$23,000.00
|
$13.52 M
|
$4.29 M
|
| EBITDA |
-$64.54 M
|
-$82.07 M
|
-$105.17 M
|
-$94.47 M
|
-$45.58 M
|
-$3.00 M
|
$3,000.00
|
| EBITDA Ratio |
-6.46 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-6.46
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$55.23 M
|
$442,000.00
|
$34,000.00
|
$505,000.00
|
$69,000.00
|
-$3.00 M
|
$3,000.00
|
| Income Before Tax |
-$119.76 M |
-$82.51 M |
-$105.58 M |
-$93.96 M |
-$45.51 M |
-$16.52 M |
-$4.28 M |
| Income Before Tax Ratio
|
-11.98
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$819,000.00 |
-$970,000.00 |
-$939,000.00 |
-$116,000.00 |
$4.87 M |
-$4.29 M |
| Net Income |
-$119.76 M |
-$81.69 M |
-$104.61 M |
-$93.02 M |
-$45.40 M |
-$16.52 M |
-$4.28 M |
| Net Income Ratio |
-11.98 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.42 |
-2.16 |
-4.09 |
-4.23 |
-3.54 |
-1.8 |
-0.47 |
| EPS Diluted |
-1.42 |
-2.16 |
-4.09 |
-4.23 |
-3.54 |
-1.8 |
-0.47 |
| Weighted Average Shares
Out |
$84.24 M
|
$37.83 M
|
$25.60 M
|
$21.97 M
|
$12.83 M
|
$9.16 M
|
$9.16 M
|
| Weighted Average Shares
Out Diluted |
$84.24 M
|
$37.83 M
|
$25.60 M
|
$21.97 M
|
$12.83 M
|
$9.16 M
|
$9.16 M
|
| Link |
|
|
|
|
|
|
|
